Myriad Genetics Inc (MYGN) — Cash Flow-to-Debt Ratio
Myriad Genetics Inc (MYGN) has a Cash Flow-to-Debt Ratio of -0.02x as of June 2026, meaning its operating cash flow of $-8.30 Million could theoretically repay 0% of its total liabilities ($335.00 Million) in one year. See MYGN financial flexibility score to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Myriad Genetics Inc Cash Flow-to-Debt Ratio (1995–2025)
Historical debt coverage capacity for Myriad Genetics Inc across 30 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Myriad Genetics Inc.
Annual Cash Flow-to-Debt Ratio for Myriad Genetics Inc (1995–2025)
Year-by-year debt coverage analysis for Myriad Genetics Inc. Check MYGN cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.01x | $1.80 Million | $338.60 Million | ▲ +120.0% |
| 2024 | -0.03x | $-8.70 Million | $326.50 Million | ▲ +91.3% |
| 2023 | -0.31x | $-110.90 Million | $363.30 Million | ▲ +10.1% |
| 2022 | -0.34x | $-106.30 Million | $312.90 Million | ▼ -744.6% |
| 2021 | 0.05x | $18.60 Million | $352.90 Million | ▼ -66.1% |
| 2020 | 0.16x | $83.70 Million | $537.80 Million | ▼ -11.9% |
| 2019 | 0.18x | $83.70 Million | $473.80 Million | ▼ -68.1% |
| 2018 | 0.55x | $115.90 Million | $209.20 Million | ▲ +130.0% |
| 2017 | 0.24x | $106.20 Million | $440.90 Million | ▼ -80.8% |
| 2016 | 1.26x | $166.30 Million | $132.40 Million | ▼ -6.9% |
| 2015 | 1.35x | $140.50 Million | $104.10 Million | ▼ -25.6% |
| 2014 | 1.81x | $190.20 Million | $104.80 Million | ▼ -21.5% |
| 2013 | 2.31x | $173.90 Million | $75.23 Million | ▼ -10.4% |
| 2012 | 2.58x | $141.80 Million | $54.98 Million | ▼ -13.2% |
| 2011 | 2.97x | $130.83 Million | $44.03 Million | ▼ -30.5% |
| 2010 | 4.28x | $155.09 Million | $36.27 Million | ▲ +63.7% |
| 2009 | 2.61x | $84.04 Million | $32.17 Million | ▲ +85.6% |
| 2008 | 1.41x | $103.74 Million | $73.69 Million | ▲ +291.6% |
| 2007 | -0.73x | $-25.85 Million | $35.18 Million | ▲ +29.7% |
| 2006 | -1.04x | $-28.03 Million | $26.82 Million | ▼ -4.4% |
| 2005 | -1.00x | $-23.30 Million | $23.29 Million | ▲ +51.1% |
| 2004 | -2.05x | $-30.88 Million | $15.08 Million | ▲ +14.9% |
| 2003 | -2.41x | $-46.54 Million | $19.34 Million | ▼ -320.8% |
| 2002 | -0.57x | $-16.31 Million | $28.52 Million | ▼ -393.6% |
| 2001 | -0.12x | $-3.78 Million | $32.58 Million | ▼ -119.4% |
| 2000 | 0.60x | $17.16 Million | $28.67 Million | ▲ +122.9% |
| 1999 | -2.61x | $-14.10 Million | $5.40 Million | ▼ -269.3% |
| 1998 | -0.71x | $-7.00 Million | $9.90 Million | ▼ -6.1% |
| 1997 | -0.67x | $-6.60 Million | $9.90 Million | ▼ -547.6% |
| 1995 | 0.15x | $1.40 Million | $9.40 Million | — |